Bacterial characteristics and glycemic control in diabetic patients with Escherichia coli urinary tract infection

Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
Ming-Cheng WangJiunn-Jong Wu

Abstract

Patients with diabetes mellitus have an increased risk of infection. The roles of bacterial characteristics and glycemic control in diabetic patients with Escherichia coli infection have not been well investigated. The aims of this study were to examine the bacterial characteristics and glycemic control in diabetic patients with E. coli infections arising in the urinary tract. A total of 271 E. coli isolates were collected from urine and bloodstream. Phylogenetic groups, the presence of virulence genes, and antimicrobial susceptibility of E. coli isolates were determined. There were few differences in E. coli bacterial characteristics between 190 diabetic and 81 nondiabetic patients. In diabetic patients with urosepsis, there was a higher hemoglobin A(1C) level, and the related E. coli strains had more neuA, papG II, afa and hlyA genes, and a lower prevalence of antimicrobial resistance to cephalosporins and fluoroquinolones than those with asymptomatic bacteriuria and urinary tract infection. Multivariate logistic regression analysis revealed that increased hemoglobin A(1C) and presence of papG II and afa genes were independent factors associated with development of urosepsis in diabetic patients. This study demonstrated that ...Continue Reading

References

Sep 30, 2000·Applied and Environmental Microbiology·O ClermontE Bingen
May 26, 2001·Diabetes Care·A G BertoniF L Brancati
Nov 1, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ming-Cheng WangJeng-Jong Huang
Mar 5, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mario BonadioOttavio Giampietro
Aug 20, 2004·Diabetic Medicine : a Journal of the British Diabetic Association·R MeilandA I M Hoepelman
Jul 12, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L M A J MullerG E H M Rutten
Sep 1, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Chin-Chung TsengJeng-Jong Huang
Sep 9, 2006·Diabetes/metabolism Research and Reviews·Anton Y PelegTimothy M E Davis
Dec 5, 2006·Diabetes Research and Clinical Practice·Ivan GornikVladimir Gasparović
Mar 3, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A G VenierX Bertrand
May 12, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M-C WangJ-J Wu
Jun 17, 2009·Journal of Medical Microbiology·Khalifa Sifaw GhengheshJohn D Klena
Feb 4, 2010·Journal of the American Geriatrics Society·Diamantis P KofteridisGeorge Samonis

❮ Previous
Next ❯

Citations

Jan 11, 2014·Current Infectious Disease Reports·Victoire de Lastours, Betsy Foxman
Feb 4, 2016·Diabetes Research and Clinical Practice·Amit Akirov, Avishay Elis
Sep 26, 2013·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Ki Wook YunIn Seok Lim
May 29, 2014·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Petra SiškováVladana Woznicová
May 2, 2016·The Journal of Urology·Sara M LenherrUNKNOWN DCCT/EDIC Research Group
Jan 15, 2017·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Chih-Chien ChiuFeng-Yee Chang
Nov 9, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yixi XieLiangliang Liu
Oct 13, 2017·Pakistan Journal of Biological Sciences : PJBS·Ali Al-AsoufiKhaled Khleifat
Dec 4, 2013·Current Opinion in Infectious Diseases·Caroline SchneebergerSuzanne E Geerlings
Feb 9, 2021·Journal of Diabetes and Metabolic Disorders·Tauseef NabiNayeem U Din Wani
Mar 6, 2021·Frontiers in Public Health·Jesús Chávez-ReyesBruno A Marichal-Cancino
Jul 13, 2019·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Chen-Hsun HoPo-Ching Cheng
May 12, 2021·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Wei-Hung LinCheng-Yen Kao
May 25, 2021·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Jun Kamei, Shingo Yamamoto
Mar 22, 2016·Microbiology Spectrum·Jérôme Tourret, Erick Denamur

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.